Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/19/2008CA2585682A1 New compound for improvement of memory function, cognitive function and mental health
10/16/2008WO2008124209A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008WO2008124184A1 Treatment of headaches, neck pain, joint pain and inflammatory-type pain
10/16/2008WO2008124153A1 Heteroaryl amide analogues as p2x7 antagonists
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/16/2008WO2008124030A1 Therapeutic agents
10/16/2008WO2008123914A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/16/2008WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
10/16/2008WO2008123592A1 A medicament for treating schizophrenia comprising cilostazol
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008WO2008122723A2 Use of poly-unsaturated fatty acids and flavonoids as active ingredients in a composition for preventing and/or treating migraines
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008122655A1 Use of helium with oxygen to provide neuroprotection
10/16/2008WO2008122654A2 Use of hyperbaric conditions to provide neuroprotection
10/16/2008WO2008122546A1 Prolinamide derivatives as modulators of voltage-gated sodium channels
10/16/2008WO2008122513A1 Heterocycles as orexin antagonists
10/16/2008WO2008122198A1 Non-steroidal androgen acceptor regulators and their medical use
10/16/2008WO2008122119A1 Perfluoroketone compounds and uses thereof
10/16/2008WO2008122104A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122102A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122101A1 Composition for promoting sleep and calmness comprising an extract of hops, eclipta alba and nordostachys jatamansi
10/16/2008WO2008122100A1 Composition for supporting restful sleep comprising valerian root extract and methylcobalamim
10/16/2008WO2008122099A1 Composition for promoting sleep and relaxation comprising lemon balm
10/16/2008WO2008122087A1 Methods for treating pervasive developmental disorders
10/16/2008WO2008101098A3 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis
10/16/2008WO2008070586A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases
10/16/2008WO2008064615A3 Crystalline and amorphous forms of rimonabant and processes for obtaining them
10/16/2008WO2007109230A3 Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
10/16/2008WO2005117550A3 Composition and method for the treatment of tauopathies
10/16/2008US20080255242 Hci polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol
10/16/2008US20080255239 Analgesics; muscular disorders; diarrhea
10/16/2008US20080255236 Methods and Composition Comprising 2-[(3-Chlorophenyl)Amino] Phenylacetic Acid for Alzheimer's Disease
10/16/2008US20080255231 Crystalline form of [3-[ alpha -(Dimethylamino)-ethyl]phenyl]-N-methylethylcarbamate hydrogentartrate
10/16/2008US20080255230 Pain therapy; muscular disorders; diarrhea
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255218 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine
10/16/2008US20080255211 cannabinoid receptors modulators; metabolic syndrome, obesity, hyperlipidemia, type II diabetes, atherosclerosis, substance addiction, liver cirrhosis, schizophrenia, sexual dysfunction, anxiety; 5-(5-(5-bromoselenophen-2-yl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-3-tert-butyl-1,2,4-oxadiazole
10/16/2008US20080255203 substituted oxadiazole and derivatives; novel allosteric modulators; nicotinic acetylcholine receptors modulators; central nervous system disorders; analgesics; 2,5-di(pyridin-3-yl)-1,3,4-oxadiazole
10/16/2008US20080255195 Psyvhological disorders; cognition activators
10/16/2008US20080255194 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255180 4-Substituted Azaadamantane Derivatives and Methods of Use Thereof
10/16/2008US20080255179 Modulate neuronal nicotinic receptor activity; attention deficit disorder, Parkinson's, Tourette's, schizophrenia, cognitive deficits, dementia; acute pain, post-surgical pain, chronic pain, inflammatory pain; 2-[1-azatricyclo[3.3.1.13,7]dec-4-ylidene]-N-(4-methylphenyl)acetamide
10/16/2008US20080255178 Azaadamantane Ester and Carbamate Derivatives and Methods of Use Thereof
10/16/2008US20080255167 Novel 2-Aminopyrimidine or 2-Aminiopyridinone Derivatives and Their Use
10/16/2008US20080255164 2-amino-6-(3-bromo-4-chlorophenyl)-5,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one trifluoroacetate; prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255156 2-Phenyl-s-triazolo[4,3-c]quinazolin-3-one derivatives; neurodegenerative and central nervous system disorders; Parkinson's and Alzheimer's disease; restless leg syndrome; sleep, attention deficit, and psychological disorders; antidepressants; strokes, psychosis
10/16/2008US20080255148 Therapeutic agent for senile dementia
10/16/2008US20080255147 Heterocycles useful as modulators of ion channels
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto
10/16/2008US20080255135 1-Aza-bicyclo[2.2.2]octane and 1-aza-bicyclo[2.2.1]heptane derivatives; psychotic, psychological, nervous system and neurodegenerative disorders; nicotinic receptor mediated diseases
10/16/2008US20080255131 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255128 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
10/16/2008US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants
10/16/2008US20080255122 Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255114 2-aminobenzoxazole carboxamides as 5ht3 modulators
10/16/2008US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands
10/16/2008US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
10/16/2008US20080255106 N-(3-Methoxypropyl)-2-[2-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-7-carboxamide hydrochloride; antidepressant, analgesic, anxiolytic agent; amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease, bipolar disease, affective disorders, depression, schizophrenia, cognitive disorder
10/16/2008US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
10/16/2008US20080255098 Compositions and Methods for Treatment of Psychiatric Disorders
10/16/2008US20080255097 Methods for the Treatment of Substance Abuse and Dependence
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255093 Compositions and methods for treating obesity and related disorders
10/16/2008US20080255088 DIBENZO[b,f][1,4]OXAZAPINE COMPOUNDS
10/16/2008US20080255086 Heterocyclic Derivatives
10/16/2008US20080255085 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders
10/16/2008US20080255076 Steroid-Derived Pharmaceutical Compositions
10/16/2008US20080255074 Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression
10/16/2008US20080255068 Tetrahydroquinoline compound; cardiovascular disorders; arteriosclerosis
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080255025 Protease inhibition
10/16/2008US20080254131 core comprising a water insoluble polymer and acetylcholinesterase inhibitor, a release rate controlling coatings is surrounding the core including a release retarding excipient; administered less frequently, provide more stable blood levels; improve pharmacokinetic; dementia, mania, nicotine dependence
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254126 health food and drink contains the pure plant extract, is for patients with abnormality in cerebral blood flow and metabolism of brain disorder; nutraceuticals; free of proanthocyanidins
10/16/2008US20080254118 Process for preparing pramipexole dihydrochloride tablets
10/16/2008US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle
10/16/2008US20080254092 Promoting wound healing and tissue regeneration; inhibiting scarring; degenerative diseases
10/16/2008US20080254073 Transdermal Patch Comprising Paroxetine
10/16/2008US20080254042 Using prolactin-releasing peptide (PrRP) to identify modulators for prevention and treatment of nervous system, heart, hepatic and anxiety disorders
10/16/2008US20080254033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254023 Using erythropoietin-producing hepatocelluar kinase receptor specific interfering RNA for treatment and prevention of brain, nervous system and spinal cord disorders
10/16/2008US20080254017 Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids
10/16/2008US20080253996 Using stromal cell-derived factor-1 (SDF-1) to treat traumatic nerve injury, pain, multiple sclerosis a nd stroke
10/16/2008US20080253989 Neuron Regeneration
10/16/2008DE202008010089U1 Exakt teilbare Filmtablette Exactly divisible tablet
10/16/2008DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008CA2683598A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008CA2683569A1 Use of hyperbaric conditions to provide neuroprotection
10/16/2008CA2682925A1 Heteroaryl amide analogues
10/16/2008CA2682872A1 Rapid dissolution of combination products
1 ... 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 ... 1833